Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

September 1, 2019; Volume 60,Issue 9

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 10A;

Discussions with Leaders

  • You have access
    A Conversation Between Joanna Fowler and Johannes Czernin
    Joanna S. Fowler and Johannes Czernin
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1191-1193; DOI: https://doi.org/10.2967/jnumed.119.233619

The State of the Art

  • You have access
    Solid-State Detector SPECT Myocardial Perfusion Imaging
    Piotr J. Slomka, Robert J.H. Miller, Lien-Hsin Hu, Guido Germano and Daniel S. Berman
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1194-1204; DOI: https://doi.org/10.2967/jnumed.118.220657

Hot Topics

  • You have access
    Training Requirements for Theranostics: A Unique Opportunity for Collaboration
    Michael M. Graham and John M. Buatti
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1205-1206; DOI: https://doi.org/10.2967/jnumed.119.228940

Continuing Education

  • You have access
    Vascular Calcification: The Evolving Relationship of Vascular Calcification to Major Acute Coronary Events
    H. William Strauss, Takehiro Nakahara, Navneet Narula and Jagat Narula
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1207-1212; DOI: https://doi.org/10.2967/jnumed.119.230276

Oncology

  • Clinical

    • Open Access
      Early Phase I Study of a 99mTc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer
      Yan Xing, Gitasha Chand, Changchun Liu, Gary J.R. Cook, Jim O’Doherty, Lingzhou Zhao, Nicholas C.L. Wong, Levente K. Meszaros, Hong Hoi Ting and Jinhua Zhao
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1213-1220; DOI: https://doi.org/10.2967/jnumed.118.224170
    • You have access
      Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer
      Gerbrand M. Kramer, Maqsood Yaqub, Herbert A. Vargas, Robert C. Schuit, Albert D. Windhorst, Alfonsus J.M. van den Eertwegh, Astrid A.M. van der Veldt, Andries M. Bergman, Eva M. Burnazi, Jason S. Lewis, Sua Chua, Kevin D. Staton, Brad J. Beattie, John L. Humm, Ian D. Davis, Andrew J. Weickhardt, Andrew M. Scott, Michael J. Morris, Otto S. Hoekstra and Adriaan A. Lammertsma
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.118.220111
    • You have access
      Frequency, Determinants, and Costs of Recommendations for Additional Imaging in Clinical 18F-FDG PET/CT Reports
      Hasan M. Alesawi, Derya Yakar, Andor W.J.M. Glaudemans and Thomas C. Kwee
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1228-1233; DOI: https://doi.org/10.2967/jnumed.118.223362
    • You have access
      Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT
      Eric C. Ehman, M. Samir El-Sady, Marie F. Kijewski, Yiu Ming Khor, Sophia Jacob, Frederick L. Ruberg, Vaishali Sanchorawala, Heather Landau, Andrew J. Yee, Giada Bianchi, Marcelo F. Di Carli, Rodney H. Falk, Hyewon Hyun and Sharmila Dorbala
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1234-1239; DOI: https://doi.org/10.2967/jnumed.118.221770
  • Basic

    • You have access
      Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro
      Xi-Feng Jin, Christoph J. Auernhammer, Harun Ilhan, Simon Lindner, Svenja Nölting, Julian Maurer, Gerald Spöttl and Michael Orth
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1240-1246; DOI: https://doi.org/10.2967/jnumed.118.224048
    • You have access
      18F-Fluoroestradiol PET Imaging of Activating Estrogen Receptor-α Mutations in Breast Cancer
      Manoj Kumar, Kelley Salem, Ciara Michel, Justin J. Jeffery, Yongjun Yan and Amy M. Fowler
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1247-1252; DOI: https://doi.org/10.2967/jnumed.118.224667

Theranostics

  • Clinical

    • You have access
      The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of 18F-Fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy
      Ur Metser, Sue Chua, Bao Ho, Shonit Punwani, Edward Johnston, Frederic Pouliot, Noam Tau, Asmaa Hawsawy, Reut Anconina, Glenn Bauman, Rodney J. Hicks, Andrew Weickhardt, Ian D. Davis, Greg Pond, Andrew M. Scott, Nina Tunariu, Harbir Sidhu and Louise Emmett
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1253-1258; DOI: https://doi.org/10.2967/jnumed.118.225185
    • You have access
      Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients
      Else A. Aalbersberg, Daphne M.V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P.M. Stokkel and Richard P. Baum
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1259-1265; DOI: https://doi.org/10.2967/jnumed.118.224386
    • FEATURED ARTICLE OF THE MONTH

      • You have access
        111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
        Thomas A. Hope, Jeremie Calais, Li Zhang, William Dieckmann and Corina Millo
        Journal of Nuclear Medicine September 1, 2019, 60 (9) 1266-1269; DOI: https://doi.org/10.2967/jnumed.118.223016
    • You have access
      First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands
      Niels J. Rupp, Christoph A. Umbricht, Daniele A. Pizzuto, Daniela Lenggenhager, Antonia Töpfer, Julian Müller, Urs J. Muehlematter, Daniela A. Ferraro, Michael Messerli, Grégoire B. Morand, Gerhard F. Huber, Daniel Eberli, Roger Schibli, Cristina Müller and Irene A. Burger
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1270-1276; DOI: https://doi.org/10.2967/jnumed.118.222307
    • You have access
      qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT
      Andrei Gafita, Marie Bieth, Markus Krönke, Giles Tetteh, Fernando Navarro, Hui Wang, Elisabeth Günther, Bjoern Menze, Wolfgang A. Weber and Matthias Eiber
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1277-1283; DOI: https://doi.org/10.2967/jnumed.118.224055
  • Basic

    • You have access
      Preclinical Evaluation and Pilot Clinical Study of Al18F-PSMA-BCH for Prostate Cancer PET Imaging
      Teli Liu, Chen Liu, Xiaoxia Xu, Fei Liu, Xiaoyi Guo, Nan Li, Xuejuan Wang, Jianhua Yang, Xing Yang, Hua Zhu and Zhi Yang
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1284-1292; DOI: https://doi.org/10.2967/jnumed.118.221671
    • FEATURED BASIC SCIENCE ARTICLE

      • Open Access
        Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
        Katrine Wickstroem, Urs B. Hagemann, Véronique Cruciani, Antje M. Wengner, Alexander Kristian, Christine Ellingsen, Gerhard Siemeister, Roger M. Bjerke, Jenny Karlsson, Olav B. Ryan, Lars Linden, Dominik Mumberg, Karl Ziegelbauer and Alan S. Cuthbertson
        Journal of Nuclear Medicine September 1, 2019, 60 (9) 1293-1300; DOI: https://doi.org/10.2967/jnumed.118.223701
    • Open Access
      Enhancement of 211At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
      Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuwei Liu, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara and Jun Hatazawa
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1301-1307; DOI: https://doi.org/10.2967/jnumed.118.222638

Cardiovascular

  • Basic

    • You have access
      In Vivo Translation of the CIRPI System: Revealing Molecular Pathology of Rabbit Aortic Atherosclerotic Plaques
      Raiyan T. Zaman, Siavash Yousefi, Hidetoshi Chibana, Fumiaki Ikeno, Steven R. Long, Sanjiv S. Gambhir, Frederick T. Chin, Michael V. McConnell, Lei Xing and Alan Yeung
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1308-1316; DOI: https://doi.org/10.2967/jnumed.118.222471

Immunology

  • Basic

    • You have access
      Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using 64Cu-αCD11b
      Qizhen Cao, Qian Huang, Chandra Mohan and Chun Li
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1317-1324; DOI: https://doi.org/10.2967/jnumed.118.220350

Radiochemistry

  • Basic

    • You have access
      Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept
      Zhengtao Qin, Carl K. Hoh, Emilia S. Olson, Amin Haghighat Jahromi, David J. Hall, Christopher V. Barback, Young-Hyun You, Motoko Yanagita, Kumar Sharma and David R. Vera
      Journal of Nuclear Medicine September 1, 2019, 60 (9) 1325-1332; DOI: https://doi.org/10.2967/jnumed.118.223727

Book Reviews

  • You have access
    Also Human: The Inner Lives of Doctors
    Vikrant R. Tadepalli and Robert Matthews
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1333; DOI: https://doi.org/10.2967/jnumed.119.232371

Letters to the Editor

  • You have access
    Improved Scatter Correction to Eliminate Halo Artifacts for 68Ga-Labeled Radiopharmaceuticals in PET Imaging
    Kristen Wangerin and Andrei Iagaru
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1334; DOI: https://doi.org/10.2967/jnumed.119.230557
  • You have access
    Reply to: Improved Scatter Correction to Eliminate Halo Artifacts for 68Ga-Labeled Radiopharmaceuticals in PET Imaging
    Maike E. Lindemann and Harald H. Quick
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1334; DOI: https://doi.org/10.2967/jnumed.119.230672
  • You have access
    The Martinique Principles
    Sukhjeet Ahuja, Anca M. Avram, Gary Dillehay, Bennett S. Greenspan, Seza Gulec and Douglas Van Nostrand
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1334-1335; DOI: https://doi.org/10.2967/jnumed.119.232066

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 11N-22N;
  • You have access
    2019 SNMMI Highlights Lecture: Neurosciences
    Henryk Barthel
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 11N-18N;
  • You have access
    Bill Targets Expanded Access to Diagnostic Radiopharmaceuticals
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 19N;
  • You have access
    Fifth Anniversary of SNMMI Professional Relations Fellowship
    Jack Slosky and Katherine Zukotynski
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 20N;
  • You have access
    SNMMI Leadership Update: Focus on International Diversity and Inclusivity
    Vasken Dilsizian
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 21N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 22N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (9)
Journal of Nuclear Medicine
Vol. 60, Issue 9
September 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
  • Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
  • Solid-State Detector SPECT Myocardial Perfusion Imaging
  • Training Requirements for Theranostics: A Unique Opportunity for Collaboration
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Hot Topics
  • Continuing Education
  • Oncology
    • Clinical
    • Basic
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Cardiovascular
    • Basic
  • Immunology
    • Basic
  • Radiochemistry
    • Basic
  • Book Reviews
  • Letters to the Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire